MedPath
FDA Approval

Acetazolamide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
October 13, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Acetazolamide(500 mg in 5 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Emcure Pharmaceuticals Limited

Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.

AVET LIFESCIENCES PRIVATE LIMITED

675467924

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acetazolamide

Product Details

NDC Product Code
23155-313
Application Number
ANDA202693
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 1, 2022
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 429ZT169UHClass: ACTIMQuantity: 500 mg in 5 mL
© Copyright 2025. All Rights Reserved by MedPath